CME in Minutes: Education in Primary Care

Please visit answersincme.com/DDT860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Robert Haddad, MD. In this activity, an expert in medical oncology discusses locally advanced head and neck squamous cell carcinoma (LA HNSCC). Upon completion of this activity, participants should be better able to: Discuss the clinical implications of the latest data for approved and recommended regimens for resectable LA HNSCC in the pre- and postoperative settings; Outline strategies to integrate immunotherapy into pre- and postoperative settings for resectable LA HNSCC, in the context of conventional treatment; and Apply multidisciplinary team approaches to effectively manage patients with LA HNSCC across pre- and postoperative treatment phases.

Please visit answersincme.com/860/103093269-replay to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Stephanie Faubion, MD, MBA, FACP, MSCP and Shelby Harris, PsyD, CBSM, DBSM. In this activity, experts in menopause discuss diagnosis and management of sleep disturbances due to vasomotor symptoms. Upon completion of this activity, participants should be better able to: Recognize the burden of menopause-related VMS occurring during sleep; Explain the clinical significance of the latest data for novel non-hormonal pharmacotherapies in the treatment of menopause-related VMS, including those occurring during sleep; Identify patients with menopause-related VMS and sleep disturbances who may benefit from a non-hormonal pharmacotherapy approach; and Formulate patient-centered management plans to enhance outcomes for patients with menopause-related VMS and sleep disturbances.

Please visit answersincme.com/RAH860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Alan G. Kaplan, MD, CCFP(EM), FCFP, CPC(HC); Sherilyn Houle, BSP, PhD, CTH, AFTM RCPS(Glasg), FISTM; and Aakash Modi, MD, CFPC, ABFM, FAAFP. In this activity, two experts in adult pneumococcal disease immunization discuss strategies to close the prevention gap in primary care and pharmacy practice. Upon completion of this activity, participants should be better able to: Describe the burden of adult pneumococcal disease in Canada, including the role of the aging immune system; Recognize opportunities for primary care physicians and pharmacists to collaborate to improve disease prevention in adults at risk for invasive pneumococcal disease; and Apply current Canadian pneumococcal vaccination recommendations into adult patient care.

Please visit answersincme.com/TNH860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Nick H. Kim, MD and Vallerie V. McLaughlin, MD. In this activity, experts in cardiovascular medicine and pulmonology discuss pulmonary arterial hypertension (PAH). Upon completion of this activity, participants should be better able to: Recognize the importance of treatment escalation for appropriate patients with PAH; Design risk-based treatment escalation plans for patients with PAH; Review the clinical impact of guideline-recommended therapies for risk-based treatment escalation in PAH; and Propose practical considerations to enhance outcomes for patients with PAH requiring treatment escalation.

Please visit answersincme.com/FAJ860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Nancy L. Kuntz, MD; Vanessa Battista, DNP, MBA, CPNP-PC, CHPPN, FPCN, FAAN; and Ethan Hilgert. In this activity, experts in the management of spinal muscular atrophy (SMA) discuss the diagnosis and treatment of late-onset SMA (type 3b, 4) in adults. Upon completion of this activity, participants should be better able to: Recognize clinical features that are suggestive of SMA in adults; Review the evidence for approved disease-modifying therapies in adult patients with SMA; and Apply strategies that address barriers to achieving optimal clinical outcomes in adults with SMA.